Skip to content

Rapport Therapeutics, Inc.

RAPP Nasdaq SEC CIK 2012593

Follow Rapport Therapeutics Weekly email: filings, results, news

News

5 stories filed under Rapport Therapeutics, grouped into ongoing threads

Bipolar

Thread · 2 stories

Rapport Therapeutics, Inc. (RAPP) Discusses RAP-219 Phase II Trial and Unmet Needs in Bipolar Mania Transcript

Markets 1 d ago

Raymond James raises Rapport Therapeutics price target on bipolar catalyst potential

Markets 38 d ago 2 sources

More coverage

Why is Rapport Therapeutics stock sliding today?

Markets 1 d ago

Rapport Therapeutics: Great CNS Science, But The Valuation Prices In Significant Success

Markets 1 d ago also on CNS

Rapport Therapeutics: A 22-Day Half-Life Creates A Differentiated Epilepsy Franchise

Markets 34 d ago

Profile

Headquarters: BOSTON, MA, United States
Sector: Healthcare
Industry: Pharmaceutical Preparations

Peers

Where this page comes from

Profile · SEC EDGAR

News · 5 stories clustered from the RSS aggregator